home / stock / bsx / bsx articles


BSX Articles, Boston Scientific Corporation - From 07/09/24

Stock Information

Company Name: Boston Scientific Corporation
Stock Symbol: BSX
Market: NYSE
Website: bostonscientific.com

Menu

BSX BSX Quote BSX Short BSX News BSX Articles BSX Message Board
Get BSX Alerts

News, Short Squeeze, Breakout and More Instantly...

Performance Comparison: Boston Scientific And Competitors In Health Care Equipment & Supplies Industry | Benzinga

In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry obse...

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,900 Today | Benzinga

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 8.59% on an annualized basis producing an average annual return ...

Reasons to Hold West Pharmaceutical in Your Portfolio Now | Benzinga

West Pharmaceutical Services, Inc. (NYSE: WST) is well poised for growth, backed by the robust Proprietary Products segment and sustained strength ...

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $6,100 Today | Benzinga

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.07% on an annualized basis producing an average annual return ...

McKesson Introduces FDA-Approved Prostate Cancer Drug | Benzinga

McKesson Corporation's (NYSE: MCK) Biologics by McKesson, its independent specialty pharmacy specializing in oncology and rare disease areas, h...

4 Medical Product Stocks to Buy From a Recovering Industry | Benzinga

The Zacks Medical – Products industry's revenues are expected to continue its growth trajectory on the back of the recovery in demand for...

BrainsWay Inks Distribution Agreement to Expand Foothold | Benzinga

BrainsWay Ltd. (NASDAQ: BWAY) recently signed an exclusive multi-year distribution agreement with a specialty distributor serving both the acute ho...

Brokers Suggest Investing in Boston Scientific: Read This Before Placing a Bet | Benzinga

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports abo...

Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal | Benzinga

Tuesday, Boston Scientific Corporation (NYSE:BSX) agreed to acquire Silk Road Medical Inc (NASDAQ:SILK) for $27.50 in cash per share, representing ...

Breaking News: Is Silk Road Medical's $27.50 Per Share Sale Price a Fair Deal? Johnson Fistel, LLP Investigates Deal Terms | Benzinga

SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a leading shareholder rights law firm, announced today that it has initiated a...

Previous 10 Next 10